1Y Annualised Return
▲15.28%
3Y Annualised Return
▲22.48%
5Y Annualised Return
▲21.53%
10Y Annualised Return
▲9.80%
Jenburkt Pharmaceuticals Stock Performance
|
|
|
Jenburkt Pharmaceuticals Company background
Founded in: 1985
Managing director: Ashish U Bhuta
Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semigovernment institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at SihorGujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research Development unit duly approved by the Ministry of Science Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, lifechanging therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 202122, the Company launched a new OTC division Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 202223.
As of 20 Aug, 2025, Jenburkt Pharmaceuticals share price is ₹1110.3. The stock opened at ₹1115.4 and had closed at ₹1099 the previous day. During today’s trading session, Jenburkt Pharmaceuticals share price moved between ₹1,100.00 and ₹1,115.45, with an average price for the day of ₹1107.72. Over the last 52 weeks, the stock has recorded a low of ₹886.10 and a high of ₹1,410.00. In terms of performance, Jenburkt Pharmaceuticals share price has increased by 8.9% over the past six months and has increased by 15.28% over the last year.
Jenburkt Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹70,24,791 (+8.07%)
Daily SIP of ₹25,000 would have become ₹70,24,791 in 1 year with a gain of ₹5,24,791 (+8.07%)
Jenburkt Pharmaceuticals Fundamental
Market Cap (in crs)
485.00
Face Value
10
Turnover (in lacs)
6.15
Key Metrics
Qtr Change %
0.8
Dividend yield 1yr %
High in industry
1.6
Jenburkt Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1110.30
Current Price
5Day EMA
1,137.30
10Day EMA
1,174.60
12Day EMA
1,186.60
20Day EMA
1,220.70
26Day EMA
1,235.20
50Day EMA
1,245.40
100Day EMA
1,213.20
200Day EMA
1,151.50
5Day SMA
1,135.80
10Day SMA
1,185.20
20Day SMA
1,246.10
30Day SMA
1,274.20
50Day SMA
1,294.10
100Day SMA
1,191.60
150Day SMA
1,151.60
200Day SMA
1,166.80
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 845 Rs | 1037 Rs |
Week Rs | 1460 Rs | 1756 Rs |
Month Rs | 919 Rs | 1138 Rs |
Resistance & Support
1,105.65
Pivot
Resistance
First Resistance
1,120.30
Second Resistance
1,141.65
Third Resistance
1,156.30
Support
First Support
1,084.30
Second support
1,069.65
Third Support
1,048.30
Relative Strength Index
27.52
Money Flow Index
15.81
MACD
-48.64
MACD Signal
-30.68
Average True Range
51.97
Average Directional Index
27.48
Rate of Change (21)
-15.43
Rate of Change (125)
0.34
Jenburkt Pharmaceuticals Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
484.00 | 646.96 | 270.25 | 567.8 | 484.00 | -1.12% | -13.50% | 53.13% | 40.94% | 113.92% | 0.00% | 12.13 | 40.64 | 1.08 | |
495.00 | 612.45 | 250 | 625 | 509.00 | -3.72% | -14.88% | 51.87% | 58.50% | 588.57% | 0.00% | 0.00 | 40.64 | 24.38 | |
152.00 | 477.42 | 126.85 | 216.45 | 152.25 | 1.13% | -1.69% | -22.72% | -15.34% | 225.56% | 0.66% | 14.60 | 46.20 | 3.93 | |
358.15 | 474.50 | 342 | 630 | 349.85 | 4.01% | -11.50% | -31.53% | -12.44% | -58.05% | 0.27% | 53.73 | 40.64 | 1.81 | |
500.21 | 635 | 1143 | 1,059.40 | 2.34% | 16.21% | 54.80% | 35.49% | 11.11% | 0.07% | 21.34 | 40.64 | 3.54 | ||
87.48 | 481.86 | 69.84 | 123.98 | 88.72 | 0.42% | -14.00% | -1.56% | -12.02% | 0.00% | 0.00% | 0.00 | 40.64 | 1.53 |
Jenburkt Pharmaceuticals Share Price FAQs
How to buy Jenburkt Pharmaceuticals shares?
You can easily buy Jenburkt Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Jenburkt Pharmaceuticals ?
The 52-week high and low of Jenburkt Pharmaceuticals share price is ₹1410 and ₹886.1 as of 20/8/2025.
Please be aware that Jenburkt Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account